Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Creatine in Treating Patients With Cancer-Associated Weight Loss
This study is not yet open for patient recruitment.
Sponsored by: | North Central Cancer Treatment Group |
---|---|
Information provided by: | National Cancer Institute (NCI) |
Purpose
RATIONALE: It is not yet known whether the supplement creatine is effective in increasing weight and improving appetite and quality of life in patients who have cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of creatine in increasing weight and improving appetite and quality of life in patients who have weight loss caused by cancer.
Condition | Treatment or Intervention | Phase |
---|---|---|
unspecified adult solid tumor, protocol specific Cachexia Anorexia weight changes |
Drug: creatine Procedure: nutritional support Procedure: supportive care/therapy |
Phase III |
MedlinePlus related topics: Cancer; Cancer Alternative Therapy; Eating Disorders
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Creatine in Patients With Cancer-Associated Weight Loss
OBJECTIVES:
OUTLINE: This is a randomized, double-blind, placebo-controlled study. Patients are stratified according to primary cancer type (lung vs gastrointestinal vs other), weight loss severity (< 10 lbs vs ≥10 lbs), age (< 50 years vs ≥ 50 years), planned concurrent chemotherapy (yes vs no), gender, and prognosis. Patients are randomized to 1 of 2 treatment arms.
Patients are followed every 6 months for up to 5 years.
PROJECTED ACCRUAL: A total of 274 patients (137 per arm) will be accrued for this study within approximately 19 months.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS: Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Cardiovascular
Other
PRIOR CONCURRENT THERAPY: Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
Location Information
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |